News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,118 Results
Type
Article (67481)
Company Profile (364)
Press Release (667271)
Multimedia
Podcasts (119)
Webinars (19)
Section
Business (205207)
Career Advice (2650)
Deals (34097)
Drug Delivery (105)
Drug Development (84412)
Employer Resources (159)
FDA (16640)
Job Trends (15014)
News (347725)
Policy (32302)
Tag
Academia (2932)
Academic (2)
Accelerated approval (9)
Adcomms (20)
Allergies (102)
Alliances (53099)
ALS (118)
Alzheimer's disease (1542)
Antibody-drug conjugate (ADC) (181)
Approvals (16626)
Artificial intelligence (355)
Autoimmune disease (34)
Automation (18)
Bankruptcy (319)
Best Places to Work (11749)
BIOSECURE Act (21)
Biosimilars (112)
Biotechnology (250)
Bladder cancer (97)
Brain cancer (39)
Breast cancer (382)
Cancer (3013)
Cardiovascular disease (231)
Career advice (2213)
Career pathing (31)
CAR-T (197)
CDC (34)
Cell therapy (550)
Cervical cancer (24)
Clinical research (68749)
Collaboration (1099)
Company closure (3)
Compensation (665)
Complete response letters (27)
COVID-19 (2850)
CRISPR (66)
C-suite (343)
Cystic fibrosis (114)
Data (3042)
Decentralized trials (2)
Denatured (46)
Depression (70)
Diabetes (358)
Diagnostics (6617)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (157)
Drug pricing (120)
Drug shortages (27)
Duchenne muscular dystrophy (125)
Earnings (82410)
Editorial (44)
Employer branding (20)
Employer resources (141)
Events (114770)
Executive appointments (894)
FDA (18337)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (986)
Gene editing (143)
Generative AI (33)
Gene therapy (412)
GLP-1 (853)
Government (4578)
Grass and pollen (5)
Guidances (179)
Healthcare (19269)
Huntington's disease (31)
IgA nephropathy (44)
Immunology and inflammation (168)
Immuno-oncology (8)
Indications (40)
Infectious disease (3033)
Inflammatory bowel disease (158)
Inflation Reduction Act (13)
Influenza (68)
Intellectual property (123)
Interviews (479)
IPO (16260)
IRA (49)
Job creations (3706)
Job search strategy (1879)
Kidney cancer (14)
Labor market (44)
Layoffs (526)
Leadership (24)
Legal (7229)
Liver cancer (84)
Lung cancer (424)
Lymphoma (208)
Machine learning (10)
Management (54)
Manufacturing (403)
MASH (97)
Medical device (13697)
Medtech (13701)
Mergers & acquisitions (18595)
Metabolic disorders (898)
Multiple sclerosis (102)
NASH (20)
Neurodegenerative disease (130)
Neuropsychiatric disorders (37)
Neuroscience (2267)
NextGen: Class of 2025 (6693)
Non-profit (4700)
Now hiring (36)
Obesity (445)
Opinion (272)
Ovarian cancer (102)
Pain (114)
Pancreatic cancer (125)
Parkinson's disease (196)
Partnered (24)
Patents (307)
Patient recruitment (166)
Peanut (53)
People (59543)
Pharmaceutical (84)
Pharmacy benefit managers (16)
Phase I (21556)
Phase II (30173)
Phase III (22452)
Pipeline (1663)
Policy (198)
Postmarket research (2858)
Preclinical (9678)
Press Release (72)
Prostate cancer (149)
Psychedelics (41)
Radiopharmaceuticals (277)
Rare diseases (491)
Real estate (6181)
Recruiting (65)
Regulatory (23077)
Reports (39)
Research institute (2629)
Resumes & cover letters (413)
Rett syndrome (10)
RNA editing (10)
RSV (53)
Schizophrenia (96)
Series A (169)
Series B (116)
Service/supplier (16)
Sickle cell disease (64)
Special edition (20)
Spinal muscular atrophy (161)
Sponsored (36)
Startups (3856)
State (1)
Stomach cancer (16)
Supply chain (77)
Tariffs (47)
The Weekly (71)
Vaccines (874)
Venture capital (52)
Weight loss (286)
Women's health (44)
Worklife (19)
Date
Last 7 days (395)
Last 30 days (1901)
Last 365 days (32339)
2025 (17356)
2024 (36479)
2023 (41302)
2022 (52622)
2021 (57036)
2020 (55219)
2019 (47669)
2018 (36069)
2017 (34211)
2016 (34030)
2015 (40211)
2014 (33448)
2013 (29521)
2012 (30296)
2011 (30507)
2010 (28798)
Location
Africa (979)
Alabama (70)
Alaska (6)
Arizona (212)
Arkansas (14)
Asia (44037)
Australia (7671)
California (7531)
Canada (2354)
China (710)
Colorado (325)
Connecticut (334)
Delaware (197)
Europe (100897)
Florida (1138)
Georgia (247)
Hawaii (1)
Idaho (53)
Illinois (648)
India (29)
Indiana (353)
Iowa (16)
Japan (235)
Kansas (113)
Kentucky (29)
Louisiana (16)
Maine (72)
Maryland (1066)
Massachusetts (5699)
Michigan (263)
Minnesota (465)
Mississippi (2)
Missouri (91)
Montana (32)
Nebraska (25)
Nevada (78)
New Hampshire (65)
New Jersey (2108)
New Mexico (31)
New York (2122)
North Carolina (1162)
North Dakota (10)
Northern California (3282)
Ohio (246)
Oklahoma (17)
Oregon (37)
Pennsylvania (1595)
Puerto Rico (14)
Rhode Island (33)
South America (1274)
South Carolina (36)
South Dakota (1)
Southern California (2808)
Tennessee (122)
Texas (1137)
United States (28139)
Utah (221)
Virginia (199)
Washington D.C. (74)
Washington State (661)
West Virginia (4)
Wisconsin (81)
735,118 Results for "biomedical advanced research and development authority barda".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium
November 5, 2024
·
6 min read
Press Releases
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
July 8, 2025
·
7 min read
Decentralized trials
Walgreens, BARDA Team in $100M Partnership to Boost Decentralized Clinical Trials
The retail pharmacy giant and the Biomedical Advanced Research and Development Authority hope to make decentralized clinical trials more accessible and representative of the U.S. population.
August 20, 2024
·
2 min read
·
Tristan Manalac
Biotech Beach
Qpex Biopharma, a Shionogi Group Company, Receives an Additional $10M Award by BARDA as Part of Qpex’s Partnership to Advance its Portfolio of Antibiotics Addressing Drug-Resistant Infections
Qpex Biopharma, Inc. today announced the exercise of a $10 million option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services, to support the advancement of the company’s antibiotic clinical development program.
May 30, 2024
·
5 min read
BARDA Selects Edesa Biotech’s Drug for U.S. Funded Platform Trial in General ARDS
Edesa Biotech, Inc. announced today that its first-in-class drug candidate has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, for evaluation in a U.S. government-funded clinical study.
June 24, 2024
·
7 min read
Press Releases
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
January 29, 2025
·
8 min read
Press Releases
Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
January 14, 2025
·
4 min read
Vaccines
Moderna to Produce Bird Flu Vaccine Under $176M BARDA Project Award
Moderna on Tuesday announced it has been awarded $176 million by a consortium funded by the Biomedical Advanced Research and Development Authority to develop an mRNA-based vaccine to counter H5N1 avian influenza.
July 2, 2024
·
2 min read
·
Tyler Patchen
Press Releases
UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
January 14, 2025
·
4 min read
Drug Development
Thermo Fisher Scientific’s PPD Clinical Research Business Selected by BARDA to Support Phase II Platform Clinical Trial to Treat Acute Respiratory Distress Syndrome (ARDS)
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been selected by the Biomedical Advanced Research and Development Authority (BARDA) to implement the first BARDA-supported Phase II platform clinical trial to investigate multiple therapeutic options for the treatment of acute respiratory distress syndrome (ARDS).
December 21, 2023
·
4 min read
1 of 73,512
Next
